About Tuberculosis (TB)
Tuberculosis, or more commonly known as TB, is caused by a bacterium called Mycobacterium tuberculosis. This bacterium typically attacks the lungs, but TB bacteria can also affect other parts of the body such as the brain, spine, and kidneys.
How is it transmitted?
Tuberculosis is an airborne disease, spread through the air from person to person when someone who has contracted TB of the lungs or throat sneezes, coughs, speaks, or sings. People in close proximity to these particles in the air may breathe them in and also become infected.
TB CANNOT spread by:
- shaking hands
- sharing foods or drinks
- bedding or toilet seats
- sharing toothbrushes or other personal hygiene items
- kissing or oral sexual contact
Signs and symptoms
Symptoms of TB include:
- a strong, persistent cough lasting 3+ weeks
- chest pains
- coughing up blood or sputum
- weight loss
- night sweats & chills
- loss of appetite
Those suffering from Tuberculosis can be treated by taking several drugs for the duration of 6 to 9 months. There are 10 drugs currently approved by the U.S. Food and Drug Administration (FDA) for treatment of TB.
In the Workplace:
Many healthcare settings have TB infection control plans that include early detection of infectious patients, precautions to avoid spread of airborne particles, and treatment of those people who have suspected or confirmed cases of TB.
Travelers should avoid being in close proximity for a prolonged period of time with known TB positive patients. Particularly in crowded, enclosed environments such as hospitals, homeless shelters, prisons, or clinics.
Travelers who will be working in or spending much time in hospitals, clinics, or other health care settings where TB patients are likely to be in close contact, should refer to the facility's infection control or occupational health regulations and consult with the experts on site to review environmental and administrative prevention procedures. Once those strategies are executed, additional precautions may include use of personal respiratory protective devices.
Travelers who anticipate potential, prolonged contact with those who have TB should receive a Tuberculin Skin Test (TST) or Interferon-Gamma Release Assay (IGRA) test before leaving the United States. If the test reaction is negative, they should have a repeat test 8 to 10 weeks once they've returned to the United States. Furthermore, yearly testing could be suggested for those who anticipate repeated or prolonged exposure or an extended stay over a period of years.
If you think you have TB or have been in close contact with someone who has confirmed TB disease, please contact Student Health Service 215-746-3535, press option 1 to speak with a nurse.